Analysis of vaccinia virus-host protein-protein interactions: Validations of yeast two-hybrid screenings

Journal of Proteome Research

Volumn 8, Issue 9, 2009, Pages 4311-4318

  Zhang, Leiliang ^a   Villa, Nancy Y ^a   Rahman, Masmudur M ^a   Smallwood, Sherin ^a   Shattuck, Donna ^b   Neff, Chris ^b   Dufford, Max ^b   Lanchbury, Jerry S ^b   LaBaer, Joshua ^c   McFadden, Grant ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Myriad Genetic Laboratories   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ORFeome; Protein protein interaction; Vaccinia virus; Yeast two hybrid

Indexed keywords

VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; EXPRESSION VECTOR; HUMAN; HYBRIDIZATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VACCINIA VIRUS; VIRUS CELL INTERACTION; VIRUS EXPRESSION; VIRUS IDENTIFICATION; VIRUS STRAIN; YEAST;

HOST-PATHOGEN INTERACTIONS; HUMANS; OPEN READING FRAMES; POLYMERASE CHAIN REACTION; PROTEIN INTERACTION MAPPING; PROTEOMICS; RECOMBINANT FUSION PROTEINS; REPRODUCIBILITY OF RESULTS; TWO-HYBRID SYSTEM TECHNIQUES; VACCINIA; VIRAL PROTEINS;

DNA VIRUSES; MONKEYPOX VIRUS; ORTHOPOXVIRUS; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 70349931825     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900491n     Document Type: Article

References (36)

1. Rual, J. F.; Hill, D. E.; Vidal, M. ORFeome projects: gateway between genomics and omics. Curr. Opin. Chem. Biol. 2004, 8 (1), 20-25. (Pubitemid 38201473)
2. Rual, J. F.; Hirozane-Kishikawa, T.; Hao, T.; Bertin, N.; Li, S.; Dricot, A.; Li, N.; Rosenberg, J.; Lamesch, P.; Vidalain, P. O.; Clingingsmith, T. R.; Hartley, J. L.; Esposito, D.; Cheo, D.; Moore, T.; Simmons, B.; Sequerra, R.; Bosak, S.; Doucette-Stamm, L.; Le Peuch, C.; Vandenhaute, J.; Cusick, M. E.; Albala, J. S.; Hill, D. E.; Vidal, M. Human ORFeome version 1.1: a platform for reverse proteomics. Genome Res. 2004, 14 (10B), 2128-2135. (Pubitemid 39440195)
3. Reboul, J.; Vaglio, P.; Tzellas, N.; Thierry-Mieg, N.; Moore, T.; Jackson, C.; Shin-i, T.; Kohara, Y.; Thierry-Mieg, D.; Thierry-Mieg, J.; Lee, H.; Hitti, J.; Doucette-Stamm, L.; Hartley, J. L.; Temple, G. F.; Brasch, M. A.; Vandenhaute, J.; Lamesch, P. E.; Hill, D. E.; Vidal, M. Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat. Genet. 2001, 27 (3), 332-336. (Pubitemid 32201858)
4. Dricot, A.; Rual, J. F.; Lamesch, P.; Bertin, N.; Dupuy, D.; Hao, T.; Lambert, C.; Hallez, R.; Delroisse, J. M.; Vandenhaute, J.; Lopez- Goni, I.; Moriyon, I.; Garcia-Lobo, J. M.; Sangari, F. J.; Macmillan, A. P.; Cutler, S. J.; Whatmore, A. M.; Bozak, S.; Sequerra, R.; Doucette-Stamm, L.; Vidal, M.; Hill, D. E.; Letesson, J. J.; De Bolle, X. Generation of the Brucella melitensis ORFeome version 1.1. Genome Res. 2004, 14 (10B), 2201-2206. (Pubitemid 39440203)
5. Brandner, C. J.; Maier, R. H.; Henderson, D. S.; Hintner, H.; Bauer, J. W.; Onder, K. The ORFeome of Staphylococcus aureus v 1.1. BMC Genomics 2008, 9, 321.
6. Condit, R. C.; Moussatche, N.; Traktman, P. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 2006, 66, 31-124. (Pubitemid 44131526)
7. Jahrling, P. B.; Fritz, E. A.; Hensley, L. E. Countermeasures to the bioterrorist threat of smallpox. Curr. Mol. Med. 2005, 5 (8), 817-826.
8. Weaver, J. R.; Isaacs, S. N. Monkeypox virus and insights into its immunomodulatory proteins. Immunol. Rev. 2008, 225, 96-113.
9. Rubins, K. H.; Hensley, L. E.; Jahrling, P. B.; Whitney, A. R.; Geisbert, T. W.; Huggins, J. W.; Owen, A.; Leduc, J. W.; Brown, P. O.; Relman, D. A. The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (42), 15190-15195.
10. Parker, S.; Nuara, A.; Buller, R. M.; Schultz, D. A. Human monkeypox: an emerging zoonotic disease. Future Microbiol. 2007, 2, 17-34.
11. McCraith, S.; Holtzman, T.; Moss, B.; Fields, S. Genome-wide analysis of vaccinia virus protein-protein interactions. Proc. Natl. Acad. Sci. U.S.A. 2000, 97 (9), 4879-4884. (Pubitemid 30238651)
12. Mohamed, M. R.; Rahman, M. M.; Lanchbury, J. S.; Shattuck, D.; Neff, C.; Dufford, M.; van Buuren, N.; Fagan, K.; Barry, M.; Smith, S.; Damon, I.; McFadden, G. Proteomic screening of variola virus reveals a unique NF-{kappa}B inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc. Natl. Acad. Sci. U.S.A. 2009, 106 (22), 9051-9056.
13. Gao, M.; Brufatto, N.; Chen, T.; Murley, L. L.; Thalakada, R.; Domagala, M.; Beattie, B.; Mamelak, D.; Athanasopoulos, V.; Johnson, D.; McFadden, G.; Burks, C.; Frappier, L. Expression profiling of herpesvirus and vaccinia virus proteins using a highthroughput baculovirus screening system. J. Proteome Res. 2005, 4 (6), 2225-2235. (Pubitemid 41814291)
14. Seet, B. T.; Johnston, J. B.; Brunetti, C. R.; Barrett, J. W.; Everett, H.; Cameron, C.; Sypula, J.; Nazarian, S. H.; Lucas, A.; McFadden, G. Poxviruses and immune evasion. Annu. Rev. Immunol. 2003, 21, 377-423.
15. Zhang, L.; Villa, N. Y.; McFadden, G. Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways. FEBS Lett. 2009, 583 (4), 607-614.
16. Gouin, E.; Welch, M. D.; Cossart, P. Actin-based motility of intracellular pathogens. Curr. Opin. Microbiol. 2005, 8 (1), 35-45.
17. Barry, M.; McFadden, G. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 1998, 10 (4), 422-430.
18. McFadden, G. Poxvirus tropism. Nat. Rev. Microbiol. 2005, 3 (3), 201-213.
19. Rogan, S.; Heaphy, S. The vaccinia virus E3L protein interacts with SUMO-1 and ribosomal protein L23a in a yeast two hybrid assay. Virus Genes 2000, 21 (3), 193-195.
20. Lin, Y. C.; Li, J.; Irwin, C. R.; Jenkins, H.; DeLange, L.; Evans, D. H. Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly. J. Virol. 2008, 82 (12), 5922-5932.
21. Sperling, K. M.; Schwantes, A.; Schnierle, B. S.; Sutter, G. The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex. Virology 2008, 374 (2), 234-239.
22. Yang, J. S.; Lee, S. Y.; Spano, S.; Gad, H.; Zhang, L.; Nie, Z.; Bonazzi, M.; Corda, D.; Luini, A.; Hsu, V. W. A role for BARS at the fission step of COPI vesicle formation from Golgi membrane. EMBO J. 2005, 24 (23), 4133-4143.
23. Doglio, L.; De Marco, A.; Schleich, S.; Roos, N.; Krijnse Locker, J. The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core. J. Virol. 2002, 76 (19), 9773-9786.
24. Kato, S. E.; Condit, R. C.; Moussatche, N. The vaccinia virus E8R gene product is required for formation of transcriptionally active virions. Virology 2007, 367 (2), 398-412. (Pubitemid 47500123)
25. Senkevich, T. G.; Wyatt, L. S.; Weisberg, A. S.; Koonin, E. V.; Moss, B. A conserved poxvirus NlpC/P60 superfamily protein contributes to vaccinia virus virulence in mice but not to replication in cell culture. Virology 2008, 374 (2), 506-514.
26. Tamin, A.; Esposito, J.; Hruby, D. A single nucleotide substitution in the 5′-untranslated region of the vaccinia N2L gene is responsible for both alpha-amanitin-resistant and temperature-sensitive phenotypes. Virology 1991, 182 (1), 393-396.
27. Lin, Y.-C. J.; Li, J.; Irwin, C. R.; Jenkins, H.,; DeLange, L.; Evans, D. H. Vaccinia Virus DNA Ligase Recruits Cellular Topoisomerase II to Sites of Viral Replication and Assembly. J. Virol. 2008, 82 (12), 5922-5932.
28. Wasilenko, S. T.; Banadyga, L.; Bond, D.; Barry, M. The vaccinia virus F1L protein interacts with the proapoptotic protein Bak and inhibits Bak activation. J. Virol. 2005, 79 (22), 14031-14043. (Pubitemid 41552701)
29. Dyer, M. D.; Murali, T. M.; Sobral, B. W. The landscape of human proteins interacting with viruses and other pathogens. PLoS Pathog, 2008, 4 (2), e32.
30. Sahu, S. K.; Gummadi, S. N.; Manoj, N.; Aradhyam, G. K. Phospholipid scramblases: an overview. Arch. Biochem. Biophys. 2007, 462 (1), 103-114.
31. Uchiyama, K.; Jokitalo, E.; Kano, F.; Murata, M.; Zhang, X.; Canas, B.; Newman, R.; Rabouille, C.; Pappin, D.; Freemont, P.; Kondo, H. VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J. Cell Biol. 2002, 159 (5), 855-866. (Pubitemid 36008367)
32. Wang, Y.; Satoh, A.; Warren, G.; Meyer, H. H. VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments. J. Cell Biol. 2004, 164 (7), 973-978.
33. Ganea, E. Chaperone-like activity of alpha-crystallin and other small heat shock proteins. Curr. Protein Pept. Sci. 2001, 2 (3), 205-225. (Pubitemid 32798792)
34. Li, Y.; Chen, B.; Chen, J.; Lou, G.; Chen, S.; Zhou, D. Fast skeletal muscle troponin I is a co-activator of estrogen receptor-related receptor alpha. Biochem. Biophys. Res. Commun. 2008, 369 (4), 1034-1040.
35. Hoover, L. L.; Kubalak, S. W. Holding their own: the noncanonical roles of Smad proteins. Sci. Signal. 2008, 1 (46), pe48.
36. Almazan, F.; Tscharke, D. C.; Smith, G. L. The vaccinia virus superoxide dismutase-like protein (A45R) is a virion component that is nonessential for virus replication. J. Virol. 2001, 75 (15), 7018-7029.